{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:09:11Z","timestamp":1790647751883,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To compare transfusion rates in patients on direct oral anticoagulants (DOACs) with nonanticoagulated patients undergoing hip fracture surgery and, secondarily, to determine whether time to surgery or complications differ between these groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Multicenter retrospective cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Three tertiary care, academic, Level I trauma centers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Acute, operatively treated, low-energy hip fracture patients 55 years of age and older were included. Anticoagulated patients were matched in a 1:2 ratio to \u201ccontrol\u201d nonanticoagulated hip fracture patients using propensity score matching.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main Outcome Measurements:<\/jats:title>\n            <jats:p>The primary outcome was incidence of perioperative transfusion. The secondary outcomes included time to surgery, length of stay, and 90-day complications, readmissions, reoperations, and mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One hundred thirty-two patients with hip fracture admitted on DOACs were identified (107 factor Xa inhibitors, 25 dabigatran) and were matched to 262 \u201ccontrol\u201d nonanticoagulated patients. There was no difference in overall transfusion rates between anticoagulation and control groups (43.2%; n = 57 DOAC vs. 39.7%; n = 104 control; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.517). The median time from admission to surgery was 41.7 hours in the DOAC group and 26.0 hours in the control group (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). There were no differences in 90-day complication, readmission, reoperation, or mortality rates between DOAC and control groups. Comparing DOAC patients undergoing surgery within 24 hours and after 24 hours, there were no differences in transfusion rates (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.558) or overall complication rates (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.179).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This study supports growing evidence that DOAC use should not be a determining factor in delaying surgery for patients with hip fracture who are otherwise medically optimized.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Level of Evidence:<\/jats:title>\n            <jats:p>Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bot.0000000000002251","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T07:01:00Z","timestamp":1630306860000},"page":"172-178","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Delayed Surgery Does Not Reduce Transfusion Rates in Low-Energy Hip Fractures on Direct Oral Anticoagulants"],"prefix":"10.1097","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9506-6322","authenticated-orcid":false,"given":"Ashley E.","family":"Levack","sequence":"first","affiliation":[{"name":"Orthopaedic Trauma Service, Hospital for Special Surgery, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold G.","family":"Moore","sequence":"additional","affiliation":[{"name":"Orthopaedic Trauma Service, Hospital for Special Surgery, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Stephan","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Cedars-Sinai Health System, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, MO; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Cedars-Sinai Health System, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Garlich","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Cedars-Sinai Health System, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Hadad","sequence":"additional","affiliation":[{"name":"Orthopaedic Trauma Service, Hospital for Special Surgery, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton T.M.","family":"Little","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Cedars-Sinai Health System, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna N.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, MO; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lyman","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Hospital for Special Surgery, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lane","sequence":"additional","affiliation":[{"name":"Orthopaedic Trauma Service, Hospital for Special Surgery, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.amjmed.2015.05.044","article-title":"National trends in ambulatory oral anticoagulant use","volume":"128","author":"Barnes","year":"2015","journal-title":"Am J Med."},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/BOT.0000000000001146","article-title":"Outcomes of early surgical intervention in geriatric proximal femur fractures among patients receiving direct oral anticoagulation","volume":"32","author":"Franklin","year":"2018","journal-title":"J Orthop Trauma"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.2106\/JBJS.RVW.18.00148","article-title":"Perioperative use of novel oral anticoagulants in orthopaedic surgery: a critical analysis review","volume":"7","author":"Eliasberg","year":"2019","journal-title":"JBJS Rev."},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12959-018-0183-3","article-title":"Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study","volume":"16","author":"Sennesael","year":"2018","journal-title":"Thromb J."},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ajem.2016.09.048","article-title":"Discontinuation and management of direct-acting anticoagulants for emergency procedures","volume":"34","author":"Levy","year":"2016","journal-title":"Am J Emerg Med."},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00590-017-1940-x","article-title":"The role of new oral anticoagulants in orthopaedics: an update of recent evidence","volume":"27","author":"Papadopoulos","year":"2017","journal-title":"Eur J Orthop Surg Traumatol."},{"key":"R7-20250614","first-page":"E161","article-title":"Periprocedural management of chronically anticoagulated patients: a practical approach to use of novel anticoagulants in orthopedic surgery","volume":"45","author":"Shamoun","year":"2016","journal-title":"Am J Orthop"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/TA.0000000000001453","article-title":"Managing hip fracture and lower limb surgery in the emergency setting: potential role of non-vitamin K antagonist oral anticoagulants","volume":"82","author":"Fisher","year":"2017","journal-title":"J Trauma Acute Care Surg."},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1001\/jama.2017.17606","article-title":"Association between wait time and 30-day mortality in adults undergoing hip fracture surgery","volume":"318","author":"Pincus","year":"2017","journal-title":"JAMA"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1503\/cmaj.092220","article-title":"Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis","volume":"182","author":"Simunovic","year":"2010","journal-title":"CMAJ"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s41999-020-00319-w","article-title":"Do direct oral anticoagulants (DOACs) cause delayed surgery, longer length of hospital stay, and poorer outcome for hip fracture patients?","volume":"11","author":"Leer-Salvesen","year":"2020","journal-title":"Eur Geriatr Med."},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/BOT.0000000000000313","article-title":"Delay in hip fracture surgery: an analysis of patient-specific and hospital-specific risk factors","volume":"29","author":"Ryan","year":"2015","journal-title":"J Orthop Trauma"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5435\/JAAOS-D-14-00432","article-title":"Management of hip fractures in the elderly","volume":"23","author":"Roberts","year":"2015","journal-title":"J Am Acad Orthop Surg."},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2018.04.022","article-title":"Morbidity and mortality after fragility hip fracture surgery in patients receiving vitamin K antagonists and direct oral anticoagulants","volume":"166","author":"Frenkel Rutenberg","year":"2018","journal-title":"Thromb Res."},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"2151459318764150","DOI":"10.1177\/2151459318764150","article-title":"Use of anticoagulants remains a significant threat to timely hip fracture surgery","volume":"9","author":"Taranu","year":"2018","journal-title":"Geriatr Orthop Surg Rehabil."},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.thromres.2015.09.017","article-title":"The impact of oral anticoagulation on time to surgery in patients hospitalized with hip fracture","volume":"136","author":"Tran","year":"2015","journal-title":"Thromb Res."},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.injury.2018.10.033","article-title":"Safety of urgent hip fracture surgery protocol under influence of direct oral anticoagulation medications","volume":"50","author":"Schermann","year":"2019","journal-title":"Injury"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00402-020-03547-8","article-title":"Outcome of older hip fracture patients on anticoagulation: a comparison of vitamin K-antagonists and Factor Xa inhibitors","volume":"141","author":"Gosch","year":"2021","journal-title":"Arch Orthop Trauma Surg."},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.3928\/01477447-20190321-02","article-title":"Surgical delay is not warranted for patients with hip fractures receiving non-warfarin anticoagulants","volume":"42","author":"Lott","year":"2019","journal-title":"Orthopedics"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inf."},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inf."},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"e020625","DOI":"10.1136\/bmjopen-2017-020625","article-title":"Should surgery be delayed in patients taking direct oral anticoagulants who suffer a hip fracture? A retrospective, case-controlled observational study at a UK major trauma centre","volume":"8","author":"Mullins","year":"2018","journal-title":"BMJ Open"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/BOT.0000000000000857","article-title":"The hip fracture patient on warfarin: evaluating blood loss and time to surgery","volume":"31","author":"Cohn","year":"2017","journal-title":"J Orthop Trauma"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.injury.2019.09.011","article-title":"Impact of oral anticoagulation on proximal femur fractures treated within 24\u2009hours: a retrospective chart review","volume":"50","author":"Schuetze","year":"2019","journal-title":"Injury"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/anae.15254","article-title":"A prospective observational study of the rapid detection of clinically-relevant plasma direct oral anticoagulant levels following acute traumatic injury","volume":"76","author":"Oberladst\u00e4tter","year":"2021","journal-title":"Anaesthesia"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-019-2347-3","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition","volume":"23","author":"Spahn","year":"2019","journal-title":"Crit Care"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med."},{"key":"R29-20250614","first-page":"CD000521","article-title":"Anaesthesia for hip fracture surgery in adults","volume":"2","author":"Guay","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"e18220","DOI":"10.1097\/MD.0000000000018220","article-title":"Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: a systematic review and meta-analysis","volume":"98","author":"Chen","year":"2019","journal-title":"Med Baltim"}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T19:01:15Z","timestamp":1749927675000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000002251","relation":{},"ISSN":["0890-5339"],"issn-type":[{"value":"0890-5339","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"2021-08-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}